Curis
CRIS
#10206
Rank
โ‚น1.54 B
Marketcap
โ‚น119.62
Share price
-1.48%
Change (1 day)
-65.95%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น330.08. In 2024 the company made an earnings per share (EPS) of -โ‚น632.29 an increase over its 2023 EPS that were of -โ‚น811.27.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.04%
2024-โ‚น632.29-22.06%
2023-โ‚น811.27-26.25%
2022-โ‚น1,10022.3%
2021-โ‚น899.41-25.37%
2020-โ‚น1,205-30.93%
2019-โ‚น1,745-2.02%
2018-โ‚น1,781
2016-โ‚น4,047-10%
2015-โ‚น4,497138.1%
2014-โ‚น1,88940%
2013-โ‚น1,349-25%
2012-โ‚น1,79966.67%
2011-โ‚น1,079

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น214.06-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น126.82-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.38-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น304.00-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.70-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น267.12-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,011 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA